T Natsume
Overview
Explore the profile of T Natsume including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
90
Citations
617
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ogawa A, Watanabe T, Natsume T, Okura E, Saito S, Kato S, et al.
J Investig Allergol Clin Immunol
. 2020 Jun;
31(1):69-71.
PMID: 32490820
No abstract available.
2.
Hara T, Nishizuka T, Yamamoto M, Iwatsuki K, Natsume T, Hirata H
Injury
. 2015 Mar;
46(7):1349-53.
PMID: 25799472
Introduction: Emergency medical technicians in Japan have experienced difficulties in identifying hospitals that will accept patients with severe finger injuries. We developed and managed a system named Interactive Teletriage using...
3.
Oh K, Yang S, Park J, Seol J, Iemura S, Natsume T, et al.
Cell Death Differ
. 2011 Feb;
18(8):1326-36.
PMID: 21293491
Apoptosis inducing factor (AIF) is a mitochondrial oxidoreductase that scavenges reactive oxygen species under normal conditions. Under certain stresses, such as exposure to N-methyl-N'-nitro-N'-nitrosoguanidine (MNNG), AIF is truncated and released...
4.
Sagara M, Kawasaki Y, Iemura S, Natsume T, Takai Y, Akiyama T
Oncogene
. 2009 Jan;
28(10):1357-65.
PMID: 19151759
The tumor suppressor adenomatous polyposis coli (APC) is mutated in sporadic and familial colorectal tumors. APC interacts with the Rac1- and Cdc42-specific guanine-nucleotide exchange factors (GEF), Asef and Asef2, which...
5.
Shimoyama T, Hamano T, Natsume T, Koizumi F, Kiura K, Tanimoto M, et al.
Pharmacogenomics J
. 2006 Mar;
6(6):388-96.
PMID: 16550209
TZT-1027 is an antimicrotubule agent targeting beta-tubulin that is undergoing clinical development. The genomic response of cancer cells to TZT-1027 was profiled to evaluate its biochemical activity. A lung cancer...
6.
Starikov E, Tanaka S, Kurita N, Sengoku Y, Natsume T, Wenzel W
Eur Phys J E Soft Matter
. 2005 Nov;
18(4):437-45.
PMID: 16314916
A novel approach to estimate DNA conductance based upon Kubo formula is presented and discussed. Using this approach, the effects of base pair mismatches, different conformational changes and base pair...
7.
Natsume T, Nakayama H, Isobe T
Trends Biotechnol
. 2002 Jan;
19(10 Suppl):S28-33.
PMID: 11780967
One of the experimental processes of functional proteomics is the analysis of protein interaction. Here, we review a new analytical platform, BIA-MS, for protein interaction analysis. BIA-MS is an integration...
8.
Natsume T, Nakamura T, Koh Y, Kobayashi M, Saijo N, Nishio K
Invest New Drugs
. 2001 Sep;
19(4):293-302.
PMID: 11561688
Clinical use of TZT-1027, a microtubule-interfering agent that inhibits the polymerization of tubulin, is expected because of its potent effects on solid tumors. TZT-1027 is thought to act directly on...
9.
Natsume T, Kobayashi M, Fujimoto S
Cancer
. 2001 Jul;
92(2):386-94.
PMID: 11466694
Background: It has been revealed that chemotherapy using DNA-damaging agents and radiotherapy were influenced by the p53 status of tumors; however, p53 status did not influence chemotherapy using antimicrotubule agents....
10.
Le Graverand M, Ou Y, Barclay L, Hart D, Natsume T, Rattner J
J Anat
. 2001 Jun;
198(Pt 5):525-35.
PMID: 11430692
Four major morphologically distinct classes of cells were identified within the adult rabbit meniscus using antibodies to cytoskeletal proteins. Two classes of cell were present in the fibrocartilage region of...